German Institute of Human Nutrition, Nuthetal, Germany.
Expert Rev Mol Diagn. 2013 Jan;13(1):35-47. doi: 10.1586/erm.12.116.
Therapeutic misconception has been extensively studied and addressed within clinical trials. An equivalent in the genetic research context has been identified as diagnostic misconception. There is not much data on this phenomenon in population-based biobank studies. Since misconceptions may generate undue motives to enroll, the authors aimed at reviewing studies addressing the reasons to participate in biobank studies. The main databases were searched using relevant keywords. Studies were included if peer-reviewed, in English and describing the reasons to enroll was provided by actual and apparently healthy donors. Although the 13 studies retrieved were heterogeneous, a scheme summarizing the main aspects involved in the decision-making process was developed. Expectation of personal benefit through health-related information was found in eight studies. Three of them discussed whether this expectation could be considered a form of therapeutic misconception. The magnitude of this phenomenon is an important ethical concern and ought to be further studied.
治疗性误解在临床试验中得到了广泛的研究和处理。在遗传研究背景下,与之相当的概念被确定为诊断性误解。在基于人群的生物库研究中,关于这种现象的数据并不多。由于误解可能会产生不必要的入组动机,作者旨在回顾研究入组原因的研究。主要数据库使用相关关键字进行搜索。如果是同行评审的、英文的,并且提供了实际和明显健康的供体的入组原因,则纳入研究。尽管检索到的 13 项研究具有异质性,但制定了一个方案来总结决策过程中涉及的主要方面。八项研究发现,通过与健康相关的信息获得个人利益的期望。其中有三项研究讨论了这种期望是否可以被视为一种治疗性误解。这种现象的程度是一个重要的伦理问题,应该进一步研究。